Why India Must Upgrade its Biosurveillance Strategy
| AUTHOR | Aditi Palo |
| DATE | October 18, 2026 |
| CATEGORIES | Advanced Biology Biosecurity |
On October 2nd, 2026, a 28-year-old laboratory researcher working at the Irkutsk Anti-Plague Research Institute of Siberia, died from ‘severe pneumonia of unknown etiology’. Although the Russian authorities ruled out the possibility of a lab-acquired plague infection, their immediate follow-up decision to quarantine numerous contacts triggered international alarm. The incident drew attention to improving the current status of biosurveillance, which is the systematic collection and analysis of data to monitor biological threats before they spread. Two weeks later, the US Army released a new biodefense strategy that had a shifted focus towards AI-based predictive biosurveillance as compared to its earlier symptomatic biosurveillance. The COVID-19 pandemic has already shown us a real-world demonstration that when early biosurveillance fails, the economy gets exponentially impacted. For a densely populated, agri-driven emerging biotech power like India, shifting from a symptomatic approach to a predictive approach in biosurveillance is not just a public health initiative but rather a pillar of national security.
As seen in Keralam’s recurring Nipah outbreaks, India has always faced a critical vulnerability to biological threats, especially from zoonotic spillovers (transmission of a pathogen from an animal host to a human). Millions of rural citizens live in close proximity to livestock and wildlife reservoirs, providing pathogens several opportunities to mutate and jump the species barrier. If a spillover event occurs, our country’s high population density guarantees high transmission velocity, thus making localized containment very difficult. With the increasing presence of biotechnology across different industries and multiple privately-owned research laboratories, India’s vulnerability to biological threats gets compounded with yet another risk - the possibility of an engineered or concentrated pathogen escaping from a laboratory. This fear is not hypothetical. In the past, there have been a couple of laboratory biosafety breaches across the world. The 2019 Brucellosis leak, which was caused by unsterilized waste gas being released from a Chinese biopharmaceutical factory, led to the immediate death of 65 workers and an eventual death of 10,000 local residents. In the same year, there was a gas explosion at the VECTOR Facility in Russia, one of the world’s few high-containment laboratories housing vials of the eradicated smallpox.
To a large extent, a robust biosurveillance infrastructure can tackle the risk of both threat categories in biosafety: natural outbreaks and bio-laboratory accidents. It can act as an early warning radar by monitoring the population and the environment to detect biological threats before they escalate into full-blown crises. Until recent initiatives, the responsibility of biosurveillance had been scattered across several ministries in India. For example, the National One Health Mission (NOHM), a cross-ministerial initiative, now oversees a geographically distributed national network of 22 BSL-3 and BSL-4 high-containment laboratories to rapidly analyze outbreak samples. In addition to this, we have the Integrated Health Information Platform (IHIP) - a web-enabled, near real-time electronic surveillance system, which requires frontline health workers in rural sub-centers, doctors, and laboratories to enter data in different fields on the IHIP mobile app. The data is geo-tagged, allowing the system to use Geographic Information Systems (GIS) to map disease clusters visually and generate automated early warning signals for many diseases. While this real-time, case-based tracking is a massive shift from the older, delayed aggregate reporting, it is still an inadequate, symptom-based system.
To ensure the nation’s biosecurity, we need to shift to a more predictive approach in biosurveillance, similar to the one that US has recently unveiled. Unlike the US, however, we fall short in having comprehensive databases and adequate financial and physical resources. Predictive biosurveillance requires a database of several streams of information - health records, environmental tracks, biological research data, and population statistics, to name a few. With limited resources in India, collection of multifactorial data for predictive biosurveillance needs targeted planning. For zoonotic spillover threats, environmental surveillance is a key component, and this can be carried out in selective areas using a risk-assessment model. Wastewater surveillance, for instance, can be carried out frequently in pre-identified hotspots such as slaughterhouses, fringes of wildlife reserves, and other categories can have assessments in proportion to their risks. The next bottleneck is transport. Shipping samples from rural hotspots to the handful of high-containment labs concentrated in major cities costs precious time, especially when compared to the highly distributed network of over 1,000 BSL-3 labs in the U.S. For regular genomic surveillance in hotspot regions, India must deploy adequate portable and rapid genomic sequencing technologies directly to the sites. The data collected from different categories of environmental surveillance can then be analyzed along with the patient data, thus making the existing IHIP tracker more holistic. For accidental lab biosafety threats, on the other hand, strict regulation and protocol schooling must be mandated in all the upcoming private biological laboratories and clinics as well. National certification programs for workers on biosafety and live-action emergency drills are some of the measures that can be carried out.
While India has never neglected biosurveillance, it must transition from a reactive biosurveillance architecture to a proactive, predictive one. Moving beyond hospital data to monitor the environment directly through portable genomic sequencing devices and regulating the booming private biotech sector on the biosafety front are measures that can be deployed with the current ecosystem. We can no longer afford to wait for the next pathogen to tear apart our economy - we must actively contain it before it does.